NASDAQ : BDSX

Biodesix, Inc. — Financial statements

Healthcare · Diagnostics & Research · United States

Last price 24.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 260.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Biodesix, Inc. (BDSX) reported revenue of 102.94M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue102.94M88.50M71.32M49.09M38.21M54.51M
Cost of Revenue18.01M16.72M15.57M13.01M14.15M30.52M
Gross Profit84.93M71.78M55.75M36.08M24.06M23.99M
Selling, General & Admin93.23M87.55M80.45M67.39M61.46M50.52M
Research & Development12.28M12.00M9.56M9.99M13.10M12.79M
Operating Expenses105.51M99.55M90.01M77.38M74.56M63.31M
Operating Income-20.58M-27.77M-34.26M-41.30M-50.51M-39.32M
Interest Expense-8.09M-7.72M-8.26M-9.54M-8.07M-4.51M
Interest & Investment Income333.00K
Other Non Operating Income (Expenses)604.00K324.00K73.00K-1.27M193.00K-9.00K
EBT Excluding Unusual Items-27.74M-35.16M-42.45M-52.10M-58.38M-43.84M
Asset Writedown-25.00K-107.00K-238.00K-44.00K-81.00K
Other Unusual Items-248.00K-6.98M676.00K
Pretax Income-27.76M-35.27M-42.93M-52.15M-65.45M-43.16M
Net Income-27.76M-35.27M-42.93M-52.15M-65.45M-43.16M
Net Income to Common-27.76M-35.27M-42.93M-52.15M-65.45M-43.16M
Shares Outstanding (Basic)8.88M7.55M6.47M4.11M2.11M1.37M
Shares Outstanding (Diluted)8.88M7.55M6.47M4.11M2.11M1.37M
EPS (Basic)-3.13-4.67-6.64-12.70-31.09-31.54
EPS (Diluted)-3.13-4.67-6.64-12.70-31.09-31.54
Free Cash Flow-20.24M-23.53M-51.88M-45.79M-48.27M-30.46M
Free Cash Flow Per Share-2.28-3.12-8.02-11.15-22.93-22.27
Gross Margin82.50%81.11%78.17%73.50%62.96%44.01%
Operating Margin-19.99%-31.37%-48.03%-84.13%-132.17%-72.14%
Profit Margin-26.97%-39.85%-60.19%-106.23%-171.27%-79.18%
Free Cash Flow Margin-19.66%-26.59%-72.74%-93.28%-126.32%-55.89%
EBITDA-15.01M-22.10M-28.49M-37.97M-46.91M-36.14M
EBITDA Margin-14.58%-24.97%-39.94%-77.35%-122.76%-66.31%
D&A For EBITDA5.58M5.67M5.77M3.33M3.60M3.18M
EBIT-20.58M-27.77M-34.26M-41.30M-50.51M-39.32M
EBIT Margin-19.99%-31.37%-48.03%-84.13%-132.17%-72.14%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents30.00M18.99M26.25M26.28M43.09M32.71M
Cash & Short-Term Investments30.00M18.99M26.25M26.28M43.09M32.71M
Receivables9.11M9.04M8.60M7.68M5.07M3.66M
Inventory1.20M1.30M1.00M1.40M1.40M2.90M
Restricted Cash100.00K100.00K100.00K100.00K100.00K100.00K
Other Current Assets3.16M3.10M3.54M4.22M3.68M4.25M
Total Current Assets43.56M32.52M39.48M39.68M53.33M43.61M
Property, Plant & Equipment29.64M30.81M31.80M29.61M8.82M4.18M
Goodwill15.03M15.03M15.03M15.03M15.03M15.03M
Other Intangible Assets2.98M3.88M5.87M7.91M9.80M11.62M
Other Long-Term Assets4.11M5.23M5.06M6.86M5.92M1.66M
Total Assets95.33M87.48M97.24M99.10M92.91M76.10M
Accounts Payable2.16M3.08M2.19M2.93M1.69M1.66M
Accrued Expenses10.41M11.03M10.06M7.71M8.22M7.67M
Current Portion of Long-Term Debt6.00K21.00K51.00K49.00K19.00K
Current Portion of Leases1.61M1.36M719.00K252.00K1.54M
Current Unearned Revenue205.00K961.00K678.00K324.00K962.00K1.85M
Other Current Liabilities906.00K992.00K641.00K22.15M10.38M17.76M
Total Current Liabilities15.29M17.44M14.32M33.42M22.84M28.96M
Long-Term Debt46.82M47.45M36.41M35.23M25.00M9.99M
Long-Term Leases23.37M24.04M24.83M25.16M5.25M
Long-Term Unearned Revenue100.00K100.00K200.00K300.00K400.00K800.00K
Other Long-Term Liabilities604.00K921.00K615.00K412.00K18.80M16.62M
Total Liabilities86.18M89.94M76.37M94.52M72.30M56.37M
Common Stock11.00K8.00K7.00K96.00K78.00K31.00K
Additional Paid-In Capital521.96M495.29M483.37M424.05M387.95M321.67M
Retained Earnings-512.83M-497.76M-462.50M-419.57M-367.42M-301.97M
Total Common Equity9.14M-2.46M20.88M4.58M20.61M19.73M
Shareholders' Equity9.14M-2.46M20.88M4.58M20.61M19.73M
Total Liabilities & Equity95.33M87.48M97.24M99.10M92.91M76.10M
Total Debt71.80M72.85M61.98M60.69M31.85M10.01M
Net Cash (Debt)-41.80M-53.87M-35.73M-34.41M11.24M22.70M
Net Cash Per Share-4.71-7.13-5.52-8.385.3416.59
Filing Date Shares Outstanding10.55M9.86M7.30M4.85M3.90M1.57M
Total Common Shares Outstanding10.55M8.25M7.27M4.81M3.88M1.54M
Working Capital28.27M15.08M25.17M6.27M30.50M14.65M
Book Value Per Share0.87-0.302.870.955.3112.81
Tangible Book Value-8.87M-21.38M-29.00K-18.36M-4.22M-6.92M
Tangible Book Value Per Share-0.84-2.59-0.00-3.82-1.09-4.50
Machinery9.30M8.72M8.36M8.44M7.23M7.97M
Construction In Progress4.00K27.00K89.00K2.95M17.00K
Leasehold Improvements28.41M28.27M28.19M24.71M2.37M2.34M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-27.76M-35.27M-42.93M-52.15M-65.45M-43.16M
Depreciation & Amortization5.62M5.67M5.77M5.51M5.84M3.18M
Asset Writedown & Restructuring Costs25.00K107.00K238.00K44.00K81.00K
Stock-Based Compensation4.06M4.14M6.64M5.37M5.96M4.94M
Provision & Write-off of Bad Debts187.00K180.00K887.00K497.00K93.00K193.00K
Other Operating Activities1.38M1.56M2.42M6.55M12.84M2.03M
Change in Accounts Receivable-1.81M-531.00K-1.81M-4.72M-1.50M11.45M
Change in Accounts Payable-117.00K1.86M1.64M513.00K-773.00K-7.42M
Change in Unearned Revenue-525.00K174.00K248.00K-755.00K-1.21M-1.68M
Change in Other Net Operating Assets-892.00K-1.17M-21.74M16.26M-857.00K2.24M
Operating Cash Flow-19.83M-23.27M-48.65M-22.87M-44.97M-28.22M
Capital Expenditures-412.00K-259.00K-3.23M-22.92M-3.30M-2.24M
Sale (Purchase) of Intangibles-157.00K-144.00K-210.00K-143.00K-236.00K-306.00K
Investing Cash Flow-569.00K-403.00K-3.44M-23.06M-3.53M-2.55M
Long-Term Debt Issued10.00M10.00M45.10M30.08M
Total Debt Issued10.00M10.00M45.10M30.08M
Long-Term Debt Repaid-21.00K-51.00K-49.00K-28.60M-45.43M
Net Debt Issued (Repaid)-15.00K9.98M-51.00K9.95M16.50M-15.35M
Issuance of Common Stock31.75M7.82M56.27M28.86M60.16M17.44M
Other Financing Activities-2.07M-1.38M-4.17M-9.68M-17.78M-828.00K
Financing Cash Flow29.67M16.42M52.05M29.13M58.88M1.26M
Net Cash Flow9.27M-7.26M-39.00K-16.80M10.38M-29.51M
Free Cash Flow-20.24M-23.53M-51.88M-45.79M-48.27M-30.46M
Free Cash Flow Margin-19.66%-26.59%-72.74%-93.28%-126.32%-55.89%
Free Cash Flow Per Share-2.28-3.12-8.02-11.15-22.93-22.27
Levered Free Cash Flow-10.89M-10.57M-36.98M-35.24M-35.38M-47.25K
Unlevered Free Cash Flow-5.83M-5.75M-31.82M-29.28M-30.33M2.77M
Cash Interest Paid6.73M6.40M7.02M3.99M1.01M1.68M
Change in Working Capital-3.34M334.00K-21.67M11.30M-4.34M4.59M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization245.37M54.10M222.56M166.48M175.94M142.97M
Enterprise Value287.17M110.42M253.11M197.38M184.27M125.06M
Last Close Price23.256.8030.6036.8046.00105.80
PS Ratio2.380.613.123.394.602.62
PB Ratio26.83-21.9510.6636.358.547.25
EV/Sales Ratio2.791.253.554.024.822.29
Debt / Equity Ratio7.85-29.552.9713.251.550.51
Net Debt / Equity Ratio4.57-21.851.717.51-0.55-1.15
Net Debt / EBITDA Ratio-2.79-2.44-1.25-0.910.240.63
Net Debt / FCF Ratio-2.06-2.29-0.69-0.750.230.74
Asset Turnover1.120.960.730.510.450.55
Inventory Turnover12.8614.5412.989.296.5810.01
Quick Ratio2.561.612.431.022.111.26
Current Ratio2.851.862.761.192.331.51
Return on Equity (ROE)-540.01%-383.09%-337.30%-414.09%-324.53%-141.75%
Return on Assets (ROA)-14.05%-18.79%-21.81%-26.89%-37.36%-24.93%
Return on Capital Employed (ROCE)-25.70%-39.60%-41.30%-62.90%-72.10%-83.40%
Earnings Yield-13.44%-65.19%-19.29%-31.32%-37.20%-30.19%
FCF Yield-8.25%-43.49%-23.31%-27.51%-27.44%-21.31%
Buyback Yield / Dilution-21.27%-16.71%-57.59%-95.03%-53.86%-465.63%